Risultati per: Aggiornamento 2024 sullo scompenso cardiaco

Annals of Internal Medicine, Volume 177, Issue 5, May 2024.

Annals of Internal Medicine, Volume 177, Issue 5, May 2024.

Annals of Internal Medicine, Volume 177, Issue 5, May 2024.

This Viewpoint discusses the 2024 presidential election in the context of the addiction and overdose crisis in the US, which has been a unifying challenge and a source of major ideological division in US politics.

New England Journal of Medicine, Volume 390, Issue 19, Page 1803-1813, May 16/23, 2024.

Circulation, Ahead of Print. AIM:The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease” provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia).METHODS:A comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate.STRUCTURE:Recommendations from the “2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease” have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed.

Promosso da Fondazione Diasorin, finale il 23 maggio a Torino

New England Journal of Medicine, Volume 390, Issue 18, Page 1712-1719, May 9, 2024.

Circulation, Ahead of Print. AimThe “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy.MethodsA comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.StructureHypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.

Circulation, Volume 149, Issue 19, Page e1164-e1164, May 7, 2024.

Stroke, Ahead of Print. The American Heart Association/American Stroke Association released a revised spontaneous intracerebral hemorrhage guideline in 2022. A working group of stroke experts reviewed this guideline and identified a subset of recommendations that were deemed suitable for creating performance measures. These 15 performance measures encompass a wide spectrum of intracerebral hemorrhage patient care, from prehospital to posthospital settings, highlighting the importance of timely interventions. The measures also include 5 quality measures and address potential challenges in data collection, with the aim of future improvements.

To the Editor On behalf of my coauthors, I write to formally request retraction of the Original Investigation, “Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial,” published online January 29, 2024, and in the March 2024 issue of JAMA Internal Medicine. Unfortunately, we have found significant coding errors that are difficult to rectify. We also discovered discrepancies in the calculation process that cast doubt on the accuracy and reliability of the reported findings. Consequently, we believe it is necessary to retract the article to uphold the integrity of scientific research and maintain the trust of our readers and the medical community. All coauthors agree with this retraction. We sincerely apologize for any inconvenience or confusion this may cause.

New England Journal of Medicine, Volume 390, Issue 16, Page 1514-1522, April 25, 2024.

Stroke, Volume 55, Issue 5, Page e148-e148, May 1, 2024.

Stroke, Volume 55, Issue 5, Page 1141-1141, May 1, 2024.

New England Journal of Medicine, Volume 390, Issue 15, Page 1421-1430, April 2024.